These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23426527)

  • 1. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier.
    Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling ferrofluid permeability across the blood–brain barrier model.
    Shi D; Sun L; Mi G; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
    Nanotechnology; 2014 Feb; 25(7):075101. PubMed ID: 24457539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model.
    Shi D; Mi G; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2016; 11():5371-5379. PubMed ID: 27799764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
    Wu VM; Huynh E; Tang S; Uskoković V
    Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
    Dan M; Bae Y; Pittman TA; Yokel RA
    Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
    Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
    Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel biomimetic material--glycine-PVA ferrofluid that crosses the blood-brain barrier.
    Nayar S; Guha A
    J Biomed Nanotechnol; 2011 Feb; 7(1):78. PubMed ID: 21485812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.
    Sun Z; Worden M; Wroczynskyj Y; Yathindranath V; van Lierop J; Hegmann T; Miller DW
    Int J Nanomedicine; 2014; 9():3013-26. PubMed ID: 25018630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-polymer functionalized aqueous ferrofluids showing high T2 relaxivity.
    Bhattacharya S; Sheikh L; Tiwari V; Ghosh M; Patel JN; Patel AB; Nayar S
    J Biomed Nanotechnol; 2014 May; 10(5):811-9. PubMed ID: 24734534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 'degradable' poly(vinyl alcohol) iron oxide nanoparticle hydrogel.
    Bannerman AD; Li X; Wan W
    Acta Biomater; 2017 Aug; 58():376-385. PubMed ID: 28499634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease.
    Alphandéry E
    Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles.
    Bommana MM; Kirthivasan B; Squillante E
    Drug Deliv; 2012 Aug; 19(6):298-306. PubMed ID: 22928708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of ultrasmall iron oxide nanoparticles from human brain-derived endothelial cells to human glioblastoma cells.
    Halamoda Kenzaoui B; Angeloni S; Overstolz T; Niedermann P; Chapuis Bernasconi C; Liley M; Juillerat-Jeanneret L
    ACS Appl Mater Interfaces; 2013 May; 5(9):3581-6. PubMed ID: 23578059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of iron oxide nanoparticle biocompatibility.
    Hanini A; Schmitt A; Kacem K; Chau F; Ammar S; Gavard J
    Int J Nanomedicine; 2011; 6():787-94. PubMed ID: 21589646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a novel biocompatible nanocomposite of graphene oxide and magnetic nanoparticles for drug delivery.
    Aliabadi M; Shagholani H; Yunessnia Lehi A
    Int J Biol Macromol; 2017 May; 98():287-291. PubMed ID: 28167110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery.
    Muldoon LL; Pagel MA; Kroll RA; Roman-Goldstein S; Jones RS; Neuwelt EA
    AJNR Am J Neuroradiol; 1999 Feb; 20(2):217-22. PubMed ID: 10094341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
    Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
    Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of glioma cells on a new co-culture in vitro blood-brain barrier model for characterization and validation of permeability.
    Mendes B; Marques C; Carvalho I; Costa P; Martins S; Ferreira D; Sarmento B
    Int J Pharm; 2015 Jul; 490(1-2):94-101. PubMed ID: 25981617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of folate conjugated superparamagnetic iron oxide nanoparticles for scintigraphic/magnetic resonance imaging.
    Chauhan RP; Mathur R; Singh G; Kaul A; Bag N; Singh S; Kumar H; Patra M; Mishra AK
    J Biomed Nanotechnol; 2013 Mar; 9(3):323-34. PubMed ID: 23620987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.